Potentiation by tumor necrosis factor of mitoxantrone cytotoxicity to human ovarian cancer cell lines
- PMID: 1517145
- PMCID: PMC5918938
- DOI: 10.1111/j.1349-7006.1992.tb01966.x
Potentiation by tumor necrosis factor of mitoxantrone cytotoxicity to human ovarian cancer cell lines
Abstract
The cytotoxic activity of human recombinant tumor necrosis factor (rHuTNF) (from 0.01 to 10000 U/ml) was assayed on six human ovarian cancer cell lines and one human cervical carcinoma cell line using a crystal violet assay. rHuTNF was cytotoxic to four cell lines (A2780, A2774, SW626, PA1), while 3 cell lines (IGROV1, SKOV3, Me180) were marginally sensitive to its activity. However, under the same experimental conditions rHuTNF markedly enhanced the cytotoxicity of mitoxantrone, a chemotherapeutic drug targeted at DNA topoisomerase II, in six cell lines. The potentiation of mitoxantrone cytotoxicity was not caused by increased drug accumulation after rHuTNF treatment. No significant increase in cytotoxicity to Me180 cell line was seen when rHuTNF was added to mitoxantrone.
Similar articles
-
Potentiation of topoisomerase I and II inhibitors cell killing by tumor necrosis factor: relationship to DNA strand breakage formation.Jpn J Cancer Res. 1992 Nov;83(11):1132-6. doi: 10.1111/j.1349-7006.1992.tb02735.x. Jpn J Cancer Res. 1992. PMID: 1336489 Free PMC article.
-
Effect of recombinant human tumor necrosis factor on A2774 human ovarian cancer cell line: potentiation of mitoxantrone cytotoxicity.Gynecol Oncol. 1991 Apr;41(1):52-5. doi: 10.1016/0090-8258(91)90254-3. Gynecol Oncol. 1991. PMID: 2026360
-
Reversal of "atypical"-multidrug resistance by recombinant human tumor necrosis factor in the human ovarian cancer cell line A2780-DX3.Oncol Res. 1993;5(8):311-23. Oncol Res. 1993. PMID: 8012063
-
Potentiation of tumour necrosis factor-mediated cell killing by VP16 on human ovarian cancer cell lines. In vitro results and clinical implications.Eur J Cancer. 1993;29A(8):1157-61. doi: 10.1016/s0959-8049(05)80307-7. Eur J Cancer. 1993. PMID: 8518027
-
Augmentation of antineoplastic effects by the combination of recombinant human tumor necrosis factor and mitoxantrone on primary culture of human ovarian cancer cells.Anticancer Res. 1992 Sep-Oct;12(5):1411-4. Anticancer Res. 1992. PMID: 1444198
Cited by
-
Potentiation of topoisomerase I and II inhibitors cell killing by tumor necrosis factor: relationship to DNA strand breakage formation.Jpn J Cancer Res. 1992 Nov;83(11):1132-6. doi: 10.1111/j.1349-7006.1992.tb02735.x. Jpn J Cancer Res. 1992. PMID: 1336489 Free PMC article.
-
Circumvention of atypical multidrug resistance with tumor necrosis factor.Jpn J Cancer Res. 1994 Feb;85(2):135-8. doi: 10.1111/j.1349-7006.1994.tb02073.x. Jpn J Cancer Res. 1994. PMID: 8144394 Free PMC article.
References
-
- ) Old , L.Tumor necrosis factor (rTNF) . Science , 230 , 630 – 636 ( 1985. ). - PubMed
-
- ) Balkwill , F. R. , Naylor , M. S. and Malik , S.Tumor necrosis factor as an anticancer agent . Eur. J. Cancer , 26 , 641 – 644 ( 1990. ). - PubMed
-
- ) Alexander , R. B. , Nelson , W. G. and Coffey , D. S.Synergistic enhancement by tumor necrosis factor of in vitro cytotoxicity from chemotherapeutic drugs targeted at DNA topoisomerase II . Cancer Res. , 47 , 2403 – 2406 ( 1987. ). - PubMed
-
- ) Utsugy , T. , Mattern , M. R. , Mirabelli , C. K. and Hanna , N.Potentiation of topoisomerase inhibitor‐induced DNA strand breakage and cytotoxicity by tumor necrosis factor: enhancement of topoisomerase activity as a mechanism of potentiation . Cancer Res. , 50 , 2636 – 2640 ( 1990. ). - PubMed
-
- ) Coffman , F. D. , Green , L. M. , Godwin , A. and Ware , C. F.Cytotoxicity mediated by tumor necrosis factor in variant subclones of Me‐180 cervical carcinoma line: modulation by specific inhibitors of DNA topoisomerase II . J. Cell. Biochem. , 39 , 95 – 105 ( 1989. ). - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical